Stock Research Monitor: MWA, and PH

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on NFEC sign up now at www.wallstequities.com/registration. Research coverage has been initiated by WallStEquities.com com on Mueller Water Products Inc. (NYSE: MWA), NF Energy Saving Corp. (NASDAQ: NFEC), and Parker-Hannifin Corp. (NYSE: PH). Companies in the Industrial Equipment and Components category are engaged in the development and production of electronic and industrial equipment. Like many industries in the industrial goods sector, this industry as a whole offers dividend yields that are well below the wider market average. All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Mueller Water Products

Atlanta, Georgia headquartered Mueller Water Products Inc.’s shares declined slightly by 0.34%, closing Thursday’s trading session at $11.62. The stock recorded a trading volume of 559,567 shares. The Company’s shares have advanced 6.90% over the previous three months. The stock is trading 2.62% above its 50-day moving average. Additionally, shares of the Company, which manufactures and markets products and services for use in the transmission, distribution, and measurement of water in the US, Canada, and internationally, have a Relative Strength Index (RSI) of 52.19.

On June 07th, 2018, Mueller Water Products priced an offering of $450,000,000 aggregate principal amount of 5.5% Senior Notes due 2026 at par. These notes are being offered in a private offering that is exempt from the registration requirements of the Securities Act of 1933. The Company intends to use the net proceeds from the offering, together with cash on hand, to repay its senior secured term loan. MWA’s complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=MWA

NF Energy Saving

On Thursday, shares in Shenyang, China-based NF Energy Saving Corp. recorded a trading volume of 620,437 shares, which was above their three months average volume of 498,850 shares. The stock rose 3.57%, ending the day at $2.61. The Company’s shares have advanced 0.60% in the past month, 83.82% in the previous three months, and 183.70% over the past year. The stock is trading above its 50-day and 200-day moving averages by 7.13% and 88.14%, respectively. Furthermore, shares of the Company, which through its subsidiaries, engages in the production and sale of energy-saving and intelligent flow control equipment in China, have an RSI of 46.30. Register for your free research report on NFEC at:

www.wallstequities.com/registration/?symbol=NFEC

Parker-Hannifin

Cleveland, Ohio headquartered Parker-Hannifin Corp.’s stock finished the day 0.57% higher at $154.83 with a total trading volume of 1.05 million shares. Shares of the Company, which manufactures and sells motion and control technologies and systems for various mobile, industrial, and aerospace markets worldwide, are trading below their 50-day moving average by 9.47%. The stock has an RSI of 24.35.

On June 21st, 2018, research firm Wells Fargo downgraded the Company’s stock rating from ‘Outperform’ to ‘Market Perform’. Wall St. Equities’ downloadable research report on PH available at:

www.wallstequities.com/registration/?symbol=PH

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504113

Stock Research Monitor: CBRE, FCE-A, and PGRE

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on WPG sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, US markets saw broad based gains with seven out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday’s session. The NASDAQ Composite ended the day at 7,503.68, up 0.79%; the Dow Jones Industrial Average edged 0.41% higher, to finish at 24,216.05; and the S&P 500 closed at 2,716.31, up 0.62%. This Friday morning, WallStEquities.com looks at the performance of these four Property Management stocks: Washington Prime Group Inc. (NYSE: WPG), CBRE Group Inc. (NYSE: CBRE), Forest City Realty Trust Inc. (NYSE: FCE-A), and Paramount Group Inc. (NYSE: PGRE). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Washington Prime Group

On Thursday, shares in Washington Prime Group Inc. recorded a trading volume of 2.37 million shares. The stock ended the session 0.12% higher at $8.14. The Company’s shares have gained 22.04% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 12.56% and 13.74%, respectively. Moreover, shares of Washington Prime, which combines a national real estate portfolio with an investment grade balance sheet, leveraging its expertise across the entire shopping center sector to increase cash flow through rigorous management of assets and provide new opportunities to retailers looking for growth throughout the US Washington Prime Group is a registered trademark of the Company, have a Relative Strength Index (RSI) of 64.01. Get the full research report on WPG for free by clicking below at:

www.wallstequities.com/registration/?symbol=WPG

CBRE Group

Los Angeles, California headquartered CBRE Group Inc.’s stock closed the day 0.47% higher at $47.35 with a total trading volume of 1.05 million shares. The Company’s shares have advanced 27.52% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 0.13% and 7.08%, respectively. Additionally, shares of CBRE Group, which operates as a commercial real estate services and investment company worldwide, have an RSI of 46.92. Access the free research report on CBRE now by signing up at:

www.wallstequities.com/registration/?symbol=CBRE

Forest City Realty Trust

Shares in Forest City Realty Trust Inc. recorded a trading volume of 1.42 million shares. The stock ended yesterday’s trading session 1.23% higher at $23.07. The Company’s shares have advanced 14.15% in the past month and 13.87% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 12.53% and 1.75%, respectively. Furthermore, shares of the Company, which engages in the ownership, development, management and acquisition of office, retail and apartment real estate throughout the US, have an RSI of 70.91. Are you already registered with Wall St. Equities? Do so now for free, and get the report on FCE-A at:

www.wallstequities.com/registration/?symbol=FCE-A

Paramount Group

Paramount Group Inc.’s stock finished Thursday’s session 0.13% higher at $15.36 with a total trading volume of 620,392 shares. The Company’s shares have advanced 7.87% over the previous three months. The stock is trading above its 50-day and 200-day moving averages by 3.29% and 1.16%, respectively. Additionally, shares of Paramount Group, which owns, operates, manages, acquires and redevelops high-quality, Class A office properties located in select central business district submarkets of New York City, Washington, DC and San Francisco, have an RSI of 56.98. Aspiring Member, please take a moment to register below for your free research report on PGRE at:

www.wallstequities.com/registration/?symbol=PGRE

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504109

Stock Research Monitor: BRFS, TSN, and PPC

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on HRL sign up now at www.wallstequities.com/registration. On Thursday, the NASDAQ Composite ended the day at 7,503.68, up 0.79%; the Dow Jones Industrial Average edged 0.41% higher, to finish at 24,216.05; and the S&P 500 closed at 2,716.31, marginally gaining 0.62%. Gains were broad based as seven out of nine sectors finished the trading session in green. WallStEquities.com has initiated research reports on the following Consumer Goods stocks: BRF S.A. (NYSE: BRFS), Hormel Foods Corp. (NYSE: HRL), Tyson Foods Inc. (NYSE: TSN), and Pilgrim’s Pride Corp. (NASDAQ: PPC). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

BRF S.A.

Itajai, Brazil headquartered BRF S.A.’s stock finished Thursday’s session 0.64% lower at $4.68 with a total trading volume of 1.44 million shares. The Company’s shares are trading below their 50-day moving average by 25.28%. Moreover, shares of BRF S.A., which focuses on raising, producing, and slaughtering poultry and pork for processing, production, and sale of fresh meat, processed products, pasta, sauce, mayonnaise, frozen vegetables, and soybean by-products, have a Relative Strength Index (RSI) of 25.37. Get the full research report on BRFS for free by clicking below at:

www.wallstequities.com/registration/?symbol=BRFS

Hormel Foods

Shares in Austin, Minnesota-based Hormel Foods Corp. rose 1.20%, ending yesterday’s session at $37.24 with a total trading volume of 3.18 million shares, which was higher than their three months average volume of 2.65 million shares. The stock has gained 8.86% over the past twelve months. The Company’s shares are trading above their 50-day and 200-day moving averages by 3.33% and 8.73%, respectively. Moreover, shares of Hormel Foods, which produces and markets various meat and food products in the US and internationally, have an RSI of 61.12. The free technical report on HRL can be accessed at:

www.wallstequities.com/registration/?symbol=HRL

Tyson Foods

On Thursday, Springdale, Arkansas headquartered Tyson Foods Inc.’s stock saw a drop of 0.03%, to close the day at $69.26. A total volume of 1.40 million shares was traded. The Company’s shares have advanced 12.49% over the last twelve months. The stock is trading below its 50-day moving average by 0.05%. Additionally, shares of Tyson Foods, which together with its subsidiaries, operates as a food company worldwide, have an RSI of 46.48. Sign up for free on Wall St. Equities and claim the latest report on TSN at:

www.wallstequities.com/registration/?symbol=TSN

Pilgrim’s Pride

Shares in Greeley, Colorado headquartered Pilgrim’s Pride Corp. ended the day 1.10% higher at $20.28. A total volume of 818,866 shares was traded. The Company’s shares are trading below their 50-day moving average by 3.21%. Furthermore, shares of Pilgrim’s Pride, which engages in the production, processing, marketing, and distribution of fresh, frozen, and value-added chicken products in the US, the UK, Europe, and Mexico, have an RSI of 48.93. See the free research coverage on PPC at:

www.wallstequities.com/registration/?symbol=PPC

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504110

Stock Research Monitor: ATHN, EVH, and HQY

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on TDOC sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, the NASDAQ Composite ended the trading session at 7,503.68, up 0.79%; the Dow Jones Industrial Average edged 0.41% higher, to finish at 24,216.05; and the S&P 500 closed at 2,716.31, slightly advancing 0.62%. Gains were broad based as seven out of nine sectors ended the day in positive. This Friday, WallStEquities.com has initiated reports coverage on the following Healthcare Information Services equities: athenahealth Inc. (NASDAQ: ATHN), Evolent Health Inc. (NYSE: EVH), HealthEquity Inc. (NASDAQ: HQY), and Teladoc Inc. (NYSE: TDOC). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

athenahealth

Watertown, Massachusetts headquartered athenahealth Inc. ‘s stock finished Thursday ‘s session 1.29% higher at $158.79 with a total trading volume of 255,199 shares. The Company ‘s shares have advanced 11.02% in the previous three months and 11.10% over the past twelve months. The stock is trading above its 50-day and 200-day moving averages by 6.20% and 16.25%, respectively. Additionally, shares of athenahealth, which together with its subsidiaries, provides network-based medical record, revenue cycle, patient engagement, care coordination, and population health services for medical groups and health systems, have a Relative Strength Index (RSI) of 64.32. Get the full research report on ATHN for free by clicking below at:

www.wallstequities.com/registration/?symbol=ATHN

Evolent Health

On Thursday, shares in Arlington, Virginia headquartered Evolent Health Inc. recorded a trading volume of 834,585 shares. The stock ended the session 1.39% higher at $21.90. The Company ‘s shares have advanced 53.68% in the previous three months. The stock is trading above its 50-day and 200-day moving averages by 10.96% and 38.28%, respectively. Moreover, shares of Evolent Health, which through its subsidiary, Evolent Health LLC, provides health care delivery and payment solutions in the US, have an RSI of 53.00.

On June 04th, 2018, research firm Piper Jaffray initiated an ‘Overweight’ rating on the Company’s stock, with a target price of $30 per share. Free research on EVH can be accessed at:

www.wallstequities.com/registration/?symbol=EVH

HealthEquity

Draper, Utah headquartered HealthEquity Inc. ‘s shares closed the day 3.83% higher at $77.05. The stock recorded a trading volume of 714,520 shares, which is above its three months average volume of 522.99 thousand shares. The Company ‘s shares have gained 27.27% over the previous three months and 50.58% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 4.56% and 33.63%, respectively. Additionally, shares of HealthEquity, which provides various solutions for managing health care accounts, health reimbursement arrangements, and flexible spending accounts for health plans, insurance companies, and third-party administrators in the US, have an RSI of 50.41. Visit WallStEquities.com now and sign up for the free research on HQY at:

www.wallstequities.com/registration/?symbol=HQY

Teladoc

Shares in Purchase, New York headquartered Teladoc Inc. finished 3.59% higher at $57.70. The stock recorded a trading volume of 1.46 million shares, which is above its three months average volume of 1.06 million shares. The Company ‘s shares have advanced 12.70% in the last month, 43.18% in the previous three months, and 59.61% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 14.26% and 46.70%, respectively. Furthermore, shares of Teladoc, which provides telehealth services worldwide, have an RSI of 56.05.

On June 05th, 2018, research firm Canaccord Genuity reiterated its ‘Buy ‘ rating on the Company ‘s stock with an increase of the target price from $47 a share to $63 a share. The free technical report on TDOC is available at:

www.wallstequities.com/registration/?symbol=TDOC

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504105

Stock Research Monitor: NTRI, SCI, and SFLY

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on HRB sign up now at www.wallstequities.com/registration. On Thursday, benchmark US indices were in bullish colors as the NASDAQ Composite closed the trading session up 0.79%; the Dow Jones Industrial Average edged 0.41% higher; and the S&P 500 was up 0.62%. US markets made broad based gains with seven out of nine sectors finishing the day in green. Pre-market today, WallStEquities.com reviews these four Personal Services stocks: H&R Block Inc. (NYSE: HRB), Nutrisystem Inc. (NASDAQ: NTRI), Service Corp. International (NYSE: SCI), and Shutterfly Inc. (NASDAQ: SFLY). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

H&R Block

Kansas City, Missouri headquartered H&R Block Inc.’s stock finished Thursday’s session 1.02% higher at $22.73. A total volume of 2.54 million shares was traded. The stock is trading below its 50-day moving average by 15.43%. Furthermore, shares of H&R Block, which through its subsidiaries, provides assisted income tax return preparation, digital DIY tax solutions, and other services and products related to income tax return preparation to the general public primarily in the US, Canada, and Australia, have a Relative Strength Index (RSI) of 26.62.

On June 14th, 2018, research firm Barrington Research reiterated its ‘Outperform’ rating on the Company’s stock with a decrease of the target price from $32 a share to $27 a share. Get the full research report on HRB for free by clicking below at:

www.wallstequities.com/registration/?symbol=HRB

Nutrisystem

Shares in Fort Washington, Pennsylvania headquartered Nutrisystem Inc. ended at $37.95, up 0.93% from the last trading session. The stock recorded a trading volume of 371,312 shares. The Company’s shares have gained 40.82% over the previous three months. The stock is trading above its 50- moving average by 11.15%. Moreover, shares of Nutrisystem, which together with its subsidiaries, provides weight management products and services for women and men in the US, have an RSI of 57.64. Gain free access to the research report on NTRI at:

www.wallstequities.com/registration/?symbol=NTRI

Service Corp. International

Houston, Texas headquartered Service Corp. International’s stock ended yesterday’s session 0.03% higher at $35.79 with a total trading volume of 797,559 shares. The Company’s shares have advanced 7.80% in the last twelve months. The stock is trading below its 50-day moving average by 3.00%. Additionally, shares of Service Corp., which provides deathcare products and services in the US and Canada, have an RSI of 42.86. Signing up today on Wall St. Equities will give you access to the latest report on SCI at:

www.wallstequities.com/registration/?symbol=SCI

Shutterfly

On Thursday, shares in Redwood City, California headquartered Shutterfly Inc. recorded a trading volume of 339,715 shares. The stock finished the day 0.18% higher at $90.62. The Company’s shares have advanced 11.53% in the previous three months and 91.26% over the last twelve months. The stock is trading above its 200-day moving average by 35.80%. Furthermore, shares of Shutterfly, which manufactures and retails personalized products and services primarily in the US, Canada, and the European Community, have an RSI of 42.60. Register now for today’s free coverage on SFLY at:

www.wallstequities.com/registration/?symbol=SFLY

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504106

Stock Research Monitor: RIGL, FOLD, and AMPE

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on SRPT sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Thursday’s trading session in bullish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Biotechnology equities this morning: Rigel Pharmaceuticals Inc. (NASDAQ: RIGL), Sarepta Therapeutics Inc. (NASDAQ: SRPT), Amicus Therapeutics Inc. (NASDAQ: FOLD), and Ampio Pharmaceuticals Inc. (NYSE AMER: AMPE). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Rigel Pharmaceuticals

On Thursday, shares in South San Francisco, California-based Rigel Pharmaceuticals Inc. recorded a trading volume of 1.43 million shares. The stock ended at $2.85, declining 2.06% from the last trading session. The Company’s shares have gained 1.42% in the last twelve months. The stock is trading below its 50-day moving average by 20.89%. Furthermore, shares of Rigel Pharma, which engages in the discovery and development of small molecule drugs for the treatment of immune and hematologic disorders, cancer, and rare diseases, have a Relative Strength Index (RSI) of 29.56. Get the full research report on RIGL for free by clicking below at:

www.wallstequities.com/registration/?symbol=RIGL

Sarepta Therapeutics

Cambridge, Massachusetts headquartered Sarepta Therapeutics Inc.’s stock finished yesterday’s session 3.47% higher at $133.75. A total volume of 2.72 million shares was traded, which was above their three months average volume of 1.75 million shares. The Company’s shares have gained 41.62% in the last month, 80.52% over the previous three months, and 295.01% in the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 37.89% and 93.63%, respectively. Furthermore, shares of Sarepta Therapeutics, which focuses on the discovery and development of RNA-based therapeutics, gene therapy, and other genetic medicine approaches for the treatment of rare neuromuscular diseases, have an RSI of 65.98.

On June 21st, 2018, research firm Robert W. Baird reiterated its ‘Outperform’ rating on the Company’s stock with an increase of the target price from $120 a share to $202 a share. To experience our free membership services anytime/ anywhere and access the free report on SRPT, click to register at:

www.wallstequities.com/registration/?symbol=SRPT

Amicus Therapeutics

At the close of trading on Thursday, shares in Cranbury, New Jersey headquartered Amicus Therapeutics Inc. saw a rise of 2.99%, ending the day at $15.50. The stock recorded a trading volume of 2.11 million shares. The Company’s shares have advanced 58.81% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 0.93% and 5.77%, respectively. Moreover, shares of Amicus Therapeutics, which engages in the discovery, development, and commercialization of medicines for various rare and orphan diseases, have an RSI of 46.74. Join our big investor community at Wall St. Equities today and get your free report on FOLD at:

www.wallstequities.com/registration/?symbol=FOLD

Ampio Pharmaceuticals

Englewood, Colorado headquartered Ampio Pharmaceuticals Inc.’s shares ended the day 0.90% higher at $2.24 with a total trading volume of 625,562 shares. The stock has gained 17.89% in the last month and 320.82% over the last twelve months. The Company’s shares are trading above their 200-day moving average by 3.64%. Additionally, shares of Ampio Pharma, which focuses on the development of therapies for the treatment of prevalent inflammatory conditions in the US, have an RSI of 58.17. Know more about AMPE in our free research coverage at:

www.wallstequities.com/registration/?symbol=AMPE

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504107

Stock Research Monitor: DXR, ELGX, and GKOS

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on VLRX sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, the NASDAQ Composite, the Dow Jones Industrial Average, and the S&P 500 edged higher at the closing bell. Seven out of nine sectors ended Thursday’s trading session in bullish territories. Taking into consideration yesterday’s market sentiment, WallStEquities.com assessed the following Medical Instruments & Supplies equities this morning: Valeritas Holdings Inc. (NASDAQ: VLRX), Daxor Corp. (NYSE AMER: DXR), Endologix Inc. (NASDAQ: ELGX), and Glaukos Corp. (NYSE: GKOS). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

Valeritas Holdings

On Thursday, shares in Bridgewater, New Jersey headquartered Valeritas Holdings Inc. recorded a trading volume of 803,238 shares. The stock ended at $1.36, declining 3.55% from the last trading session. The stock is trading below its 50-day moving average by 17.28%. Furthermore, shares of Valeritas Holdings, which focuses on the development and commercialization of technologies to treat patients with Type-2 diabetes in the US and China, have a Relative Strength Index (RSI) of 39.70. Get the full research report on VLRX for free by clicking below at:

www.wallstequities.com/registration/?symbol=VLRX

Daxor

New York headquartered Daxor Corp.’s stock finished yesterday’s session 5.20% higher at $6.68. A total volume of 3,659 shares was traded. The stock is trading above its 200-day moving average by 13.12%. Furthermore, shares of Daxor, which provides biotechnology and cryobanking services in the US, have an RSI of 49.60. Get access to our top-rated research, including the free report on DXR at:

www.wallstequities.com/registration/?symbol=DXR

Endologix

At the close of trading on Thursday, shares in Irvine, California headquartered Endologix Inc. saw a drop of 0.17%, ending the day at $5.82. The stock recorded a trading volume of 541,613 shares. The Company’s shares have advanced 37.59% in the previous three months and 16.87% over the last twelve months. The stock is trading above its 50-day and 200-day moving averages by 10.64% and 20.12%, respectively. Moreover, shares of Endologix, which develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the US and internationally, have an RSI of 51.38. Click here to subscribe for a free membership which welcomes you with our report on ELGX at:

www.wallstequities.com/registration/?symbol=ELGX

Glaukos

San Clemente, California headquartered Glaukos Corp.’s shares ended the day 0.49% higher at $41.03 with a total trading volume of 251,067 shares. The stock has gained 10.41% in the last month and 33.08% in the previous three months. The Company’s shares are trading above their 50-day and 200-day moving averages by 12.29% and 28.44%, respectively. Additionally, shares of Glaukos, which focuses on the development and commercialization of surgical devices and sustained pharmaceutical therapies designed to treat glaucoma, have an RSI of 54.73.

On June 21st, 2018, research firm JP Morgan downgraded the Company’s stock rating from ‘Overweight’ to ‘Neutral’. To get free access to your research report on GKOS, sign up at:

www.wallstequities.com/registration/?symbol=GKOS

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504102

Stock Research Monitor: BXS, OZRK, and CSFL

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on BBT sign up now at www.wallstequities.com/registration. On Thursday, June 28, 2018, US markets saw broad based gains with seven out of nine sectors finishing the trading sessions in green. Major US indices were also bullish at the close of yesterday’s session. The NASDAQ Composite ended the day at 7,503.68, up 0.79%; the Dow Jones Industrial Average edged 0.41% higher, to finish at 24,216.05; and the S&P 500 closed at 2,716.31, up 0.62%. This Friday morning, WallStEquities.com looks at the performance of these four Regional – Southeast Banks stocks: BancorpSouth Bank (NYSE: BXS), Bank of the Ozarks (NASDAQ: OZRK), BB&T Corp. (NYSE: BBT), and CenterState Bank Corp. (NASDAQ: CSFL). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

BancorpSouth Bank

On Thursday, shares in Tupelo, Mississippi headquartered BancorpSouth Bank recorded a trading volume of 661,994 shares, which was above their three months average volume of 644.37 thousand shares. The stock ended the session 1.36% higher at $33.60. The Company’s shares have gained 10.89% in the past twelve months. The stock is trading above its 200-day moving average by 2.81%. Moreover, shares of BancorpSouth Bank, which operates as a financial holding company for BancorpSouth Bank that provides commercial banking and financial services to individuals and small-to-medium size businesses, have a Relative Strength Index (RSI) of 43.74. Get the full research report on BXS for free by clicking below at:

www.wallstequities.com/registration/?symbol=BXS

Bank of the Ozarks

Little Rock, Arkansas headquartered Bank of the Ozarks’ stock closed the day 0.31% lower at $45.12 with a total trading volume of 592,190 shares. The stock is trading below its 50-day moving average by 5.76%. Additionally, shares of Bank of the Ozarks, which provides a range of retail and commercial banking services to businesses, individuals, and non-profit and governmental entities, have an RSI of 26.87.

On June 18th, 2018, research firm Citigroup initiated a ‘Buy’ rating on the Company’s stock, with a target price of $62 per share. OZRK’s complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=OZRK

BB&T

Shares in Winston-Salem, North Carolina headquartered BB&T Corp. recorded a trading volume of 2.88 million shares. The stock ended yesterday’s trading session 0.08% lower at $50.65. The Company’s shares have advanced 13.20% in the past twelve months. The stock is trading below its 50-day moving average by 5.32%. Furthermore, shares of BB&T Corp., which operates as a financial holding company that provides various banking and trust services for small and mid-size businesses, public agencies, local governments, and individuals, have an RSI of 29.54. Register for your free research report on BBT at:

www.wallstequities.com/registration/?symbol=BBT

CenterState Bank

Winter Haven, Florida headquartered CenterState Bank Corp.’s stock finished Thursday’s session 0.83% higher at $30.28 with a total trading volume of 551,253 shares. The Company’s shares have advanced 14.13% over the previous three months and 22.29% in the past twelve months. The stock is trading above its 200-day moving average by 9.83%. Additionally, shares of CenterState Bank, which operates as the holding company for CenterState Bank, N.A. that provides various consumer and commercial banking services to individuals, businesses, and industries in Florida, have an RSI of 44.82.

On May 29th, 2018, research firm Raymond James downgraded the Company’s stock rating from ‘Outperform’ to ‘Market Perform’. Wall St. Equities’ downloadable research report on CSFL available at:

www.wallstequities.com/registration/?symbol=CSFL

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504103

Stock Research Monitor: CDTI, CLWT, and LIQT

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on AQUA sign up now at www.wallstequities.com/registration. WallStEquities.com covers the Pollution and Treatment Controls space, which is engaged in the design, development, and production of filtration systems and pollution control products for consumer and industrial use.In this morning’s lineup are these four stocks: CDTi Advanced Materials Inc. (NASDAQ: CDTI), Euro Tech Holdings Co. Ltd (NASDAQ: CLWT), Evoqua Water Technologies Corp. (NYSE: AQUA), and LiqTech International Inc. (NYSE AMER: LIQT). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

CDTi Advanced Materials

Oxnard, California headquartered CDTi Advanced Materials Inc.’s stock finished Thursday’s session flat at $0.58 with a total trading volume of 69,027 shares. The stock is trading below their 50-day moving average by 12.16%. Shares of the Company, which provides technology and solutions to the automotive emissions control markets in the US, Canada, Sweden, France, Japan, Asia, and the UK, have a Relative Strength Index (RSI) of 45.51.

On June 18th, 2018, CDTi Advanced Materials announced the Company’s intent to commence a rights offering pursuant to which it plans to raise approximately $3,424,500 through the distribution of subscription rights and the exercise thereof (the “Rights Offering”). Under the proposed Rights Offering, the Company will distribute non-transferable subscription rights to purchase one share of Common Stock for each share of Common Stock outstanding at a subscription price per share of $0.50 to its stockholders of record as of June 28th, 2018. Get the full research report on CDTI for free by clicking below at:

www.wallstequities.com/registration/?symbol=CDTI

Euro Tech Holdings

Shares in Hong Kong, Hong Kong headquartered Euro Tech Holdings Co. Ltd ended at $4.00, declining 1.23% from the last trading session. The stock recorded a trading volume of 51,498 shares. The Company’s shares have gained 6.87% in the last month, 76.97% in the previous three months, and 42.72% over the past year. The stock is trading 4.14% above its 50-day moving average and 26.69% above its 200-day moving average. Moreover, shares of Euro Tech, which through its subsidiaries, distributes water treatment equipment, laboratory instruments, analyzers, test kits and related supplies, and power generation equipment in Hong Kong and China, have an RSI of 44.55. CLWT’s complimentary research coverage is a few simple steps away at:

www.wallstequities.com/registration/?symbol=CLWT

Evoqua Water Technologies

Pittsburgh, Pennsylvania headquartered Evoqua Water Technologies Corp.’s stock ended yesterday’s session 0.34% higher at $20.67. A total volume of 892,333 shares was traded, which was above their three months average volume of 761,890 shares. The Company’s shares have advanced 5.24% in the past month. The stock is trading 2.87% above its 50-day moving average. Additionally, shares of the Company, which provides a range of water and wastewater treatment systems and technologies, and mobile and emergency water supply solutions and services, have an RSI of 59.10.

On June 20th, 2018, Evoqua Water Technologies (“AQUA”) announced that one of its wholly owned subsidiaries has signed a definitive agreement to purchase ProAct Services Corporation (“ProAct Services”), a provider of on-site treatment services of contaminated water in all 50 US states, from private equity firm Hammond, Kennedy, Whitney & Company Inc. and members of management for $132 million. Upon closing, ProAct Services will operate as a separate division within AQUA’s Industrial Segment and will continue to be based in Ludington, Michigan.Are you already registered with Wall St. Equities? Do so now for free, and get the report on AQUA at:

www.wallstequities.com/registration/?symbol=AQUA

LiqTech International

On Thursday, shares in Ballerup, Denmark headquartered LiqTech International Inc. recorded a trading volume of 138,870 shares. The stock finished 0.03% higher at $0.75. The Company’s shares have advanced 16.26% in the last month, 51.42% in the previous three months, and 138.10% over the past year. The stock is trading above its 50-day and 200-day moving averages by 27.50% and 64.82%, respectively. Furthermore, shares of LiqTech International, which provides technologies for gas and liquid purification by manufacturing ceramic silicon carbide filters, have an RSI of 62.50. Aspiring Member, please take a moment to register below for your free research report on LIQT at:

www.wallstequities.com/registration/?symbol=LIQT

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504093

Stock Research Monitor: PNM, SRE, and TERP

LONDON, UK / ACCESSWIRE / June 29, 2018 / If you want a free Stock Review on NRG sign up now at www.wallstequities.com/registration. Pre-market, WallStEquities.com revisits the Diversified Utilitiesindustry, which consists of companies that provide consumers and businesses with electricity, natural gas, and water. Most of these companies are government-sanctioned monopolies. They operate without competition in their main service areas. Under review this morning are the following four equities: NRG Energy Inc. (NYSE: NRG), PNM Resources Inc. (NYSE: PNM), Sempra Energy (NYSE: SRE), and TerraForm Power Inc. (NASDAQ: TERP). All you have to do is sign up today for this free limited time offer by clicking the link below.

www.wallstequities.com/registration

NRG Energy

On Thursday, shares in Princeton, New Jersey headquartered NRG Energy Inc. recorded a trading volume of 3.96 million shares. The stock ended the session 0.71% lower at $30.71. The Company’s shares have gained 0.59% over the previous three months and 77.31% over the past year. The stock is trading 6.83% above its 200-day moving average. Moreover, shares of NRG Energy, which together with its subsidiaries, operates as an integrated power company in the US, have a Relative Strength Index (RSI) of 35.60.

On June 12th, 2018, NRG Energy (NRG) and Cypress Creek Renewables, one of the largest integrated solar energy companies in the US, announced a joint project where the latter will develop and operate 25 megawatts of solar projects for NRG to support commercial and industrial customers. The environmentally-friendly solar installations will be the foundation of a new type of simplified fixed-price renewable energy plan for large businesses, adding an innovative dimension to a proven product structure. Get the full research report on NRG for free by clicking below at:

www.wallstequities.com/registration/?symbol=NRG

PNM Resources

Albuquerque, New Mexico headquartered PNM Resources Inc.’s stock closed the day flat at $38.95 with a total trading volume of 257,975 shares. The Company’s shares have advanced 1.83% in the previous three months. The stock is trading 1.50% above its 50-day moving average. Additionally, shares of PNM Resources, which through its subsidiaries, engages in the energy and energy-related businesses in the US, have an RSI of 57.22.

On June 19th, 2018, PNM’s Board of Directors, a subsidiary of PNM Resources, has declared the regular quarterly dividend of$1.145per share on the 4.58% series of cumulative preferred stock. The preferred stock dividend is payableJuly 15th, 2018, to shareholders of record at the close of businessJuly 02nd, 2018. Today’s complimentary research report on PNM is accessible at:

www.wallstequities.com/registration/?symbol=PNM

Sempra Energy

Shares in San Diego, California headquartered Sempra Energy recorded a trading volume of 2.46 million shares, which was higher than their three months average volume of 2.39 million shares. The stock ended yesterday’s trading session 0.71% lower at $115.11. The Company’s shares have advanced 8.35% in the past month, 3.50% in the previous three months, and 1.71% over the past year. The stock is trading above its 50-day and 200-day moving averages by 5.86% and 3.28%, respectively. Furthermore, shares of Sempra Energy, which together with its subsidiaries, invests in, develops, and operates energy infrastructure, as well as provides electric and gas services in the US and internationally, have an RSI of 59.57.

On June 12th, 2018, research firm Wells Fargo downgraded the Company’s stock rating from ‘Outperform’ to ‘Market Perform’.

On June 20th, 2018, Sempra Energy’s Board of Directors declared a quarterly dividend of$0.8950per share of common stock, payableon July 15th, 2018, to common stock shareholders of record at the close of business onJuly 02nd, 2018. The Board also declared a quarterly dividend of$1.50per share on the Company’s 6% Mandatory Convertible Preferred Stock, Series A, payableon July 15th, 2018, to Preferred Stock, Series A shareholders of record as ofJuly 01st, 2018. Sign up for free on Wall St. Equities and claim the latest report on SRE at:

www.wallstequities.com/registration/?symbol=SRE

TerraForm Power

Bethesda, Maryland headquartered TerraForm Power Inc.’s stock finished Thursday’s session 0.51% lower at $11.66 with a total trading volume of 606,069 shares. The Company’s shares have advanced 2.91% in the last month, 8.67% over the previous three months, and 16.18% over the past year. The stock is trading above its 50-day and 200-day moving averages by 4.25% and 1.51%, respectively. Additionally, shares of TerraForm Power, which together with its subsidiaries, owns and operates clean power generation assets, have an RSI of 61.21.

On June 11th, 2018, TerraForm Power (TERP) announced that it has issued 60,975,609 shares to certain affiliates of its sponsor Brookfield Asset Management and has received net proceeds of $650 million that it plans to use to fund the acquisition of 100% of the outstanding shares of Saeta Yield, S.A. TERP’s total shares outstanding now total 209,061,636. See the free research coverage on TERP at:

www.wallstequities.com/registration/?symbol=TERP

Wall St. Equities:

Wall St. Equities (WSE) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. WSE has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

WSE has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:

The non-sponsored content contained herein has been prepared by a writer (the “Author”) and is fact checked and reviewed by a third-party research service company (the “Reviewer”) represented by a credentialed financial analyst [for further information on analyst credentials, please email info@wallstequities.com. Rohit Tuli, a CFA® charterholder (the “Sponsor”), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by WSE. WSE is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.

NO WARRANTY

WSE, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. WSE, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, WSE, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither WSE nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit

https://wallstequities.com/legal-disclaimer/

CONTACT

For any questions, inquiries, or comments reach out to us directly. If you’re a company, we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:

Email: info@wallstequities.com
Phone number: 21 32 044 483
Office Address: 1 Scotts Road #24-10, Shaw Center Singapore 228

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE: Wall St. Equities

ReleaseID: 504095